GIA
PDLI

Gargoyle Investment Advisor’s PDL BioPharma, Inc. PDLI Stock Holding History

Gargoyle Investment Advisor’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,200
Closed -$38K – 120
2019
Q1 		$38K Sell
10,200
-2,000
-16% -$6.75K 0.04% 113
2018
Q4 		$35K Buy
+12,200
New +$33.5K 0.03% 103

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Gargoyle Investment Advisor's PDLI Position: Q4 2015 in Review

Gargoyle Investment Advisor sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 64,473 shares — an estimated $324K sold.

Gargoyle Investment Advisor first reported a position in PDLI in Q2 2013 and held it in 10 quarters. The position peaked at $624K in Q2 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

  • Gargoyle Investment Advisor reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 64,473 PDL BioPharma, Inc. shares in Q4 2015, an estimated $324K.
  • Gargoyle Investment Advisor first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 10 quarters.
  • Gargoyle Investment Advisor's PDL BioPharma, Inc. position peaked at $624K in Q2 2014.
  • 204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Gargoyle Investment Advisor's 13F filing for Q4 2015, filed 27 Jan 2016.